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245 Abstract
46 The comet assay offers the opportunity to measure both DNA damage and repair. Various 
47 comet assay based methods are available to measure DNA repair activity, but some 
48 requirements should be met for their effective use in human biomonitoring studies. These 
49 conditions include i) robustness of the assay, ii) sources of inter- and intra-individual variability 
50 must be known, iii) DNA repair kinetics should be assessed to optimize sampling timing; and iv) 
51 DNA repair in accessible surrogate tissues should reflect repair activity in target tissues prone 
52 to carcinogenic effects. DNA repair phenotyping can be performed on frozen and fresh 
53 samples, and is a more direct measurement than genomic or transcriptomic approaches. There 
54 are mixed reports concerning the regulation of DNA repair by environmental and dietary 
55 factors. In general, exposure to genotoxic agents did not change base excision repair (BER) 
56 activity, whereas some studies reported that dietary interventions affected BER activity. On 
57 the other hand, in vitro and in vivo studies indicated that nucleotide excision repair (NER) can 
58 be altered by exposure to genotoxic agents, but studies on other life style related factors, such 
59 as diet, are rare. Thus, crucial questions concerning the factors regulating DNA repair and 
60 inter-individual variation remain unanswered. Intra-individual variation over a period of days 
61 to weeks seems limited, which is favourable for DNA repair phenotyping in biomonitoring 
62 studies. Despite this reported low intra-individual variation, timing of sampling remains an 
63 issue that needs further investigation. A correlation was reported between the repair activity 
64 in easily accessible peripheral blood mononuclear cells (PBMCs) and internal organs for both 
65 NER and BER. However, no correlation was found between tumour tissue and blood cells. In 
66 conclusion, although comet assay based approaches to measure BER/NER phenotypes are 
67 feasible and promising; more work is needed to further optimize their application in human 
68 biomonitoring and intervention studies.
69
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372 1. Introduction
73 1.1. DNA damage and repair 
74 Human DNA is exposed to both exogenous and endogenous agents that can modify its 
75 structure. These structural alterations can take different forms: breaks in the sugar-phosphate 
76 backbone affecting one or both strands [i.e., single strand breaks (SSBs) or double strand 
77 breaks (DSBs)], oxidation or alkylation of bases, large molecules covalently linked to DNA bases 
78 (bulky DNA-adducts), proteins linked to DNA bases (protein-DNA cross links), covalent bonds 
79 between bases in the same strand (intra-strand cross links) or in different strands (inter-strand 
80 cross links), and wrongly paired bases [1]. These DNA lesions can affect transcription but, more 
81 importantly, if not repaired or if mis-repaired before the replication process, they can induce 
82 mutations. Mutations in key genes (e.g. genes that control DNA repair, DNA replication, cell 
83 cycle control or chromosome segregation and apoptosis) are involved in the development of 
84 cancer and other degenerative diseases [2].
85 DNA repair systems, involving different groups of proteins, amend the majority of DNA 
86 damages before permanent genome changes can occur. Different DNA repair pathways deal 
87 with the various kinds of DNA lesions (see table 1). For instance, SSBs are repaired by the 
88 insertion of one or a few bases followed by ligation, while DSBs are repaired by more 
89 complicated processes, namely homologous recombination and non-homologous end-joining 
90 pathways (the latter being error-prone and therefore potentially mutagenic). Small base 
91 alterations such as oxidised and alkylated bases are predominantly repaired by the base 
92 excision repair system (BER), involving removal of the damaged base by a specific glycosylase, 
93 excision of the resulting baseless sugar, insertion of correct nucleotides using the opposite 
94 strand as template and ligation. More complex lesions such as bulky adducts, inter- and intra-
95 strand cross links, and protein-DNA cross links are repaired by the nucleotide excision repair 
96 system (NER), in which an oligonucleotide containing the damage is excised and replaced with 
97 the correct nucleotides. Finally, wrongly paired bases are repaired by the mismatch repair 
98 system.  For more details on each DNA repair mechanism, we refer to two comprehensive 
99 reviews [1, 4]. 
100 DNA repair activity is regarded as a valuable human biomarker, reflecting susceptibility to the 
101 accumulation of mutations and thus to cancer, the assumption being that a high intrinsic 
102 repair activity will reduce the likelihood of damage being present at replication. Repair activity 
103 is frequently assessed by measuring the level of transcription of selected genes from different 
104 DNA repair pathways or by the detection of gene polymorphisms (the latter often have 
4105 unknown consequences). However, the activity of an enzyme does not entirely depend on 
106 transcription and DNA repair is actually regulated in a post-translational manner, so a 
107 phenotypic or functional assay is more direct. Moreover, phenotypic analyses take into 
108 account the influence of environmental factors. Different phenotypic approaches based on the 
109 comet assay have been used to monitor DNA repair in human samples, but the question 
110 remains whether these assays are suitable for application in human biomonitoring studies. 
111 The COST Action hCOMET (‘The comet assay in human biomonitoring’, CA15132, 
112 http://www.hcomet.org) with more than 60 researchers from 25 countries is addressing the 
113 application of the comet assay (single cell gel electrophoresis) to measure both DNA damage 
114 and DNA repair in human samples. This article has been prepared in the framework of this 
115 project as a starting point for further validation trials of the comet assay for assessing DNA 
116 repair activity. A working group on DNA repair measurements using the comet assay has 
117 identified the required conditions for using DNA repair phenotyping in human biomonitoring 
118 studies. These conditions include: 1) technical robustness of the assay; analysis of DNA repair 
119 activity by the comet assay must have advantages compared to other techniques; 2) sources of 
120 inter- and intra-individual variability must be identified; 3) DNA repair kinetics should be 
121 assessed to optimize sampling timing; and 4) DNA repair in accessible surrogate tissues should 
122 reflect repair activity in target tissues (i.e. tissues prone to carcinogenic effects). Here we 
123 describe the current status of these aspects in the scientific literature. 
124 In this review, we predominantly included human biomonitoring studies that focussed on 
125 assessing DNA repair activity by comet assay approaches (see next section) in easily accessible 
126 tissues or cells. The comet assay-based repair assays are continuously and successfully being 
127 validated while at the same time being applied in various research studies. Scientific 
128 achievements emerge at the same time as initiatives to understand the assays, improving their 
129 reliability, and extending the applications to new tissues. The status of the assays is not 
130 advanced to a state where standardized protocols have been adopted. Substantial 
131 heterogeneity exists between studies, which very much depends on variation in assay 
132 conditions [5]. Although, meta-analysis is an integrate part of systematic reviews, the present 
133 variability in the comet assay-based DNA repair assays precludes a meaningful meta-analysis. 
134 Thus, only qualitative outcomes of the individual studies will be discussed her.
135
136 1.1.1 The comet assay 
5137 Although the alkaline comet assay (single cell gel electophoresis) was primarily developed as a 
138 method to measure DNA damage, it has also been used to measure DNA repair. The standard 
139 version of the comet assay measures DNA strand breaks (SBs) in individual cells. The protocol 
140 is simple [6]: briefly, cells are embedded in agarose, placed on a microscope slide and lysed to 
141 remove membranes and soluble components (including histones) leaving nucleoids (i.e., 
142 supercoiled DNA attached at intervals to a nuclear matrix forming loops) [7]. After that, 
143 nucleoids are exposed to an alkaline treatment and to alkaline electrophoresis. The presence 
144 of breaks in the DNA relaxes the supercoiled loops and enables the DNA to migrate towards 
145 the anode. Finally, DNA is stained with a DNA fluorescent dye and visualized by fluorescence 
146 microscopy, revealing images similar to the stellar comets. The more breaks that are present, 
147 the more DNA is able to migrate to the anode. The percentage of DNA in the comet tail 
148 represents the frequency of DNA SBs and is measured by image analysis. It is worth to mention 
149 that DNA cross-links have the opposite effect; they inhibit the migration of the DNA loops. 
150 About 50-150 cells (comets) are evaluated per sample and the mean or median value is 
151 normally calculated as the descriptor of the sample. Visual scoring methods  have been used, 
152 though it is currently not the method of choice. In this system, comets are visually classified in 
153 5 categories according to the intensity of the comet tail and head [8]. Each comet is given a 
154 value between 0 and 4; 0 for undamaged comets and 4 for the comets with almost all DNA in 
155 their tail. The overall score is calculated by applying the following formula: (percentage of cells 
156 in class 0 x 0) + (percentage of cells in class 1 x 1) + (percentage of cells in class 2 x 2) + 
157 (percentage of cells in class 3 x 3) + (percentage of cells in class 4 x 4). Consequently, the total 
158 score is in the range from 0 to 400 arbitrary units (AU). This system gives reliable results when 
159 applied by an experienced operator and is comparable to the scores obtained using image 
160 analysis systems [9].  
161 The digestion of the nucleoids (i.e., naked DNA remaining after the lysis of the cells) with lesion 
162 specific enzymes allows the detection of other lesions such oxidises bases [10]. 
163 Formamidopyrimidine DNA glycosylase (Fpg) is the most used in order to detect 8-oxo-7,8-
164 dihydroguanine (8-oxoGua) though it also detects other DNA lesions. 
165
166 1.2 Comet based approaches to measure DNA repair
167 1.2.1 Cellular repair assays
168 The most straightforward approach to measure DNA repair activity is to induce DNA damage in 
169 cells and subsequently monitor the rate of repair/removal of these lesions over time. 
6170 Interestingly, the comet assay was developed to measure DNA repair from the very beginning; 
171 followed the reduction in the number of radiation-induced breaks with time, which represents 
172 the repair of those lesions [11]. Singh et al., used what is now referred to as a ‘challenge assay’ 
173 or ‘cellular repair assay’ (as it will be called in the rest of this paper), which follows the kinetics 
174 of removal of a certain DNA lesion and re-ligation of the remaining SB with time (Figure 1) [11]. 
175 SB re-ligation following X- or ɣ-irradiation, or H2O2 treatment has been extensively studied in 
176 human biomonitoring [12], but it is possible to monitor the removal of other DNA lesions such 
177 as oxidised and alkylated bases, and UV-induced cyclobutane pyrimidine dimers, using 
178 appropriate enzymes to convert the lesions to SBs [6]. The specificity of the cellular repair 
179 assay, regarding the DNA repair pathway that is measured, depends on the DNA-damaging 
180 agent, the version of the comet assay (i.e., with or without enzymes) and the substrate 
181 specificity of the enzyme used.
182  The advantage of this assay is that the entire DNA repair process is assessed, since it depends 
183 on the restoration of the normal DNA structure. Moreover, since DNA repair is measured at a 
184 cellular level, the presence of cell populations with different DNA repair capacity can in theory 
185 be detected. However, from a technical point of view, it is rather complicated to measure 
186 repair in this way, because it requires hours of cell culture and sampling at intervals for comet 
187 assay analysis, highly limiting the number of samples that can be analysed at the same time. 
188 The fact that cells (normally white blood cells) are under ex vivo conditions might also 
189 influence the DNA repair process. Although there is no direct evidence to support this notion, 
190 the higher ex vivo oxygen tension, compared to the in vivo conditions, could for instance alter 
191 the repair process. Moreover, interpretation of the results is complicated by the fact that DNA-
192 damaging agents may induce different amounts of lesions in different subjects, so that repair 
193 starts at different substrate concentrations [12]. This may be particularly important if the initial 
194 amount of damage is too high, reaching the point of saturation of the comet assay.   
195
196 1.2.2 Inhibitor-based cellular repair assay
197 DNA repair capacity can also be measured by including polymerase inhibitors such as 
198 aphidicolin or cytosine arabinoside in the cellular repair assay; in this way, removal of the 
199 affected nucleotide occurs, but the re-synthesis step to fill the gap in DNA is inhibited  [13-15]. 
200 As a result, the normally transient SBs accumulate to an extent which reflects the repair 
201 capacity of the cells. Although from a technical point of view this assay is simple, its application 
202 in human biomonitoring studies is very rare. The assay has been successfully used to assess 
7203 NER capacity [14, 15], but it is worth mentioning that some authors have reported that the 
204 DNA breaks produced during NER are not necessarily transient in freshly isolated lymphocytes 
205 and are detectable with the comet assay without using additional polymerase inhibitors  [16, 
206 17]. In any case, the use of polymerase inhibitors may increase the sensitivity of the assay by 
207 increasing the %DNA in the tail and avoids misinterpretation of the results (e.g. inter-individual 
208 differences resulting from different precursor pool sizes rather than actual differences in 
209 repair). The application of this method to biomonitoring requires further investigation and 
210 validation. 
211
212 1.2.3 In vitro DNA repair assays
213 As an alternative to assessing repair carried out by intact cells, a more biochemical approach - 
214 referred to as in vitro DNA repair assay- has been developed. This approach is based on the 
215 capability of repair proteins in a cell extract to recognize and incise substrate DNA that 
216 contains specific lesions. The whole-cell extract can be prepared from lymphocytes, ground 
217 tissues or cultured cells, by ‘snap-freezing’ and subsequent lysis with Triton X-100. At the 
218 moment, there are distinct types of in vitro DNA repair assay. 
219 One of these approaches uses closed circular plasmids containing specific lesions as substrate. 
220 When incubated with the cell extract, repair enzymes within this extract can incise the plasmid 
221 close to the lesion and the resulting nicked (repaired) or closed (unrepaired) plasmids can be 
222 separated by gel electrophoresis [18]. In an alternative version of this plasmid assay, the cell 
223 extract is incubated with the plasmid in the presence of 32P-labelled deoxyribonucleoside 
224 triphosphates and repair can be estimated by the incorporation of radioactive precursors into 
225 a repair patch [19]. In this way the plasmid assay measures the overall repair starting from 
226 incision to repair synthesis. Alternatively, the cell extract can be incubated with an 
227 oligonucleotide that is constructed with a specific DNA lesion and a terminal radioactive or 
228 fluorescent tag [20, 21]. The repair enzymes in the extract will cut the oligonucleotide at the 
229 damaged site, causing the release of the label or a change in the size of the single stranded 
230 oligonucleotide, which can be measured as an indicator for DNA repair. 
231 Although these methods have been applied in human biomonitoring studies, especially by  
232 Paz-Elizur et al. ([22-24])  and Leitner-Dagan, et al. ([25, 26]), the number of studies in which 
233 these techniques were applied is limited. The comet assay on the other hand has been used as 
234 an in vitro DNA repair assay more often and its principle plus multiple applications has recently 
235 been reviewed [3, 10]. The DNA incision activity of a cellular extract is measured by incubating 
8236 it with agarose-embedded nucleoids containing specific lesions as substrate (nucleoids can be 
237 derived from established cell lines or white blood cells) (Figure 2). The DNA repair enzymes in 
238 the cell extracts will recognize the damage in the substrate nucleoids and induce repair 
239 incisions. The comet assay reveals the incision activity of the enzymes by the accumulation of 
240 breaks in the substrate nucleoids. (It seems that the pool of deoxynucleotide triphosphates 
241 (dNTPs) in peripheral blood mononuclear cells (PBMC) is so limited and diluted that the re-
242 synthesis stage of DNA repair cannot take place. When dNTPs are added to the cellular extract, 
243 DNA synthesis and ligation occurs and breaks/incisions are no longer detected [27].
244 Thus, the nature of the DNA lesions in the substrate defines the type of DNA repair that is 
245 measured. BER and NER have been extensively studied using this approach [28]. In the case of 
246 the in vitro BER assay, substrate nucleoids are commonly produced by treating cells with the 
247 photosensitiser Ro 19-8022 and subsequent irradiation with visible light or cells are treated 
248 with potassium bromate  to produce 8-oxoguanine (8-oxoG) [29, 30]. For the in vitro NER 
249 assay, substrate nucleoids are produced by treating cells with benzo[a]pyrene-diol epoxide 
250 (BPDE) to induce bulky adducts [31], with UV(C) to induce pyrimidine dimers [32], or with 
251 oxiplatin to induce cross-links [33]. In these in vitro assays, the incision activity is considered to 
252 be the rate-limiting step of the DNA repair process, and is measured as an indicator of the DNA 
253 repair activity. This method is more convenient for human biomonitoring studies than the 
254 cellular assay, since several samples can be easily analysed at the same time and it can be 
255 performed with frozen samples [34]. Most of the publications using the in vitro repair assay to 
256 measure DNA repair activity in humans use lymphocytes or PBMCs. There are few human 
257 studies using tissue samples; to the best of our knowledge only colon has been analysed [33, 
258 35, 36]. 
259
260 2. Technical validation and optimizations
261 The cellular repair comet assay and the in vitro repair comet assay for BER and NER have been 
262 extensively used in assessing DNA repair for biomonitoring purposes. However, although 
263 several protocols regarding the different approaches have been published, most laboratories 
264 use their own protocols, which leads to significant variations in procedures and potential 
265 difficulties in carrying out inter-laboratory comparisons of results. In fact, all techniques used 
266 in molecular epidemiology should be validated before routine use, so that there can be 
267 confidence in the results, and comparability between laboratories and studies.
268
9269 2.1. Cellular repair assay – optimizations & lack of validation
270 Protocols to carry out the cellular repair assay, covering the measurement of repair of SBs, 
271 oxidised bases (BER) and UV-induced pyrimidine dimers (NER), were published by Collins and 
272 Azqueta [37]. As mentioned in the introduction, this is a simple but tedious approach. 
273 According to our knowledge, though the approach has been extensively used, validation 
274 studies have not been carried out (or published) and there are still some pending technical 
275 issues. Foremost, the effect of the type of DNA-damaging agent on DNA repair activity has not 
276 been tested (e.g. X-, ɣ-irradiation, vs. H2O2 to induce SBs; different photosensitisers plus light 
277 vs. potassium bromate to induce oxidised bases; UVC-light vs. BPDE to induce lesions repaired 
278 by NER). Additionally, analysis of results is an issue since individuals can vary in the level of 
279 damage induced experimentally in the test cells, due to differing individual susceptibility to the 
280 DNA-damaging agent (e.g. varying antioxidant status leading to different levels of base 
281 oxidation). Therefore, the use of t½ (i.e. the period of time at which half of the DNA damage 
282 has been repaired) could be a good option in order to compare results among different 
283 individuals, assuming first order kinetics, because t½ may be independent of the initial amount 
284 of damage [37].      
285 The approach of measuring DNA repair by blocking polymerase and re-ligation after incision 
286 using DNA polymerase inhibitors has been described as a potential tool to be used in human 
287 biomonitoring studies, but it has not yet been applied in large scale studies [15, 38]. It presents 
288 the same unsolved technical issues as the cellular repair assay.
289
290 2.2. The validity of the in vitro repair assay 
291 Collins and Azqueta described the practical details for applying the in vitro repair assay [37] 
292 and a detailed protocol to carry out this assay in cultured cell lines, blood cells, animal tissues 
293 and human biopsies, was published in 2013 [34]. The protocol includes practical tips and 
294 recommendation for setting up the assays. This is the most convenient adaptation of the 
295 comet assay to measure DNA repair in human biomonitoring studies and several technical 
296 validations have been carried out. 
297 The usefulness of the in vitro BER assay was demonstrated several times since the very first 
298 paper in which the approach was described, measuring the repair activity of extracts from 
299 cells/tissues of OGG1 knockout cells and mice in comparison to wild type (WT) material. In all 
300 cases the activity decreased or completely disappeared in knockout samples [29, 36, 39, 40]. 
301 The usefulness of the in vitro repair assay to assess NER activity was demonstrated by Langie et 
10
302 al. using extracts of cell lines established from patients with xeroderma pigmentosum (XPA-/-, 
303 XPC-/-) and WT fibroblasts [31]. They found lower DNA incision activity when extracts from the 
304 knockout cells were used and, as expected, the activity was restored to normal WT values 
305 when mixing the extracts of XPC and XPA mutants, because they complement each other. 
306 Slyskova et al. measured the NER repair activity of extract from liver of XPG-/- and WT mice, 
307 showing that knockout mice had no more activity than the negative control incubations with 
308 reaction buffer alone [36].
309 The protein concentration of extracts can be measured and concentration adjusted, though 
310 Collins et al. reckoned that determining the extract concentration on basis of the cell numbers 
311 is sufficiently accurate when using lymphocytes [29]. However, in some cases cells are lost 
312 during centrifugation; and the extraction efficiency of proteins can differ slightly between 
313 batches. Therefore, it is recommended that the concentration of proteins should be measured 
314 in each extract [34]. In the case of extracts from tissues, the protein estimation is essential [40, 
315 41], since tissue samples consist of an unknown number of cells, containing a mixture of cell 
316 types and connective tissue.
317 The incision activity at different extract protein concentrations normally shows a non-linear 
318 relation or a linear but not proportional relationship between incision and concentration. 
319 Collins et al., showed a linear but not proportional relationship of extract concentration and 
320 BER activity when 0.25X, 0.5X and 1X extract was used [29].  Guarnieri et al. also found a linear 
321 but non-proportional relationship when testing the BER activity of different mouse liver extract 
322 concentrations (0.001, 0.01, 0.1 and 1x) [39]. In an experiment testing different concentrations 
323 of extract from human colon biopsies (0-18 mg protein/ml), a non-linear relationship was 
324 reported: a non-proportional increase in activity was seen until 3 mg/mL followed by a 
325 decrease at higher concentrations [36]. The authors explained that too high protein 
326 concentration saturated the reaction. In the same study, similar effects were observed when 
327 the NER incision activity was measured. Likewise, when testing human lymphocytes or 
328 cultured fibroblast for their NER activity; high protein concentrations caused a lower relative 
329 difference between the total damage-related incision activity and non-specific incisions [31]. 
330 Therefore, when working with tissues, extract dilution curves should be performed to 
331 elucidate the protein concentration showing the maximum activity, since important 
332 differences in the optimal concentration among tissues (especially between proliferative and 
333 non-proliferative tissues) have been shown in animals [40, 41]. This probably also applies when 
334 using human tissues. 
11
335 Heat inactivation of extracts from animal tissues demonstrated that the SBs in substrate DNA 
336 are produced by enzymes contained in the extract and so the assay is measuring enzyme 
337 activity [40-42]. Slyskova et al. used aphidicolin or ABT888, inhibitors of the post-incision 
338 (repair synthesis) phase of BER and NER respectively, to check if they could increase the 
339 specificity of the assay and prevent underestimation of the detected incision activity of the 
340 protein extracts (from human colon biopsies) [36]. Incision activity could be underestimated 
341 due to the presence of some level of repair synthesis occurring. However, if that were the 
342 case, the inhibitors would have enhanced the yield of breaks, but this was not observed [36].  
343 The lack of non-specific nucleases in extracts from lymphocytes has been demonstrated by the 
344 low level of SBs present in untreated substrates [29]. However, significant non-specific 
345 nuclease activity was detected in extracts from animal tissues [40, 41]. In this case, altering the 
346 reaction buffer was used as strategy to decrease the non-specific enzyme activity (adding 
347 proteinase inhibitors, ATP, polyAT) [40, 41]. Although these changes decreased the non-
348 specific nuclease activity, a simultaneous decrease in repair-specific incision activity was 
349 observed. Interestingly, aphidicolin may have an inhibitory effect on various nucleases that are 
350 not related to DNA repair processes. For instance it had been demonstrated to inhibit Herpes 
351 Simplex virus DNA polymerase-associated nuclease activity [43], as well as the 3’5’ 
352 exonuclease activity of eukaryotic polymerases  and  [44, 45]. Only the use of aphidicolin 
353 significantly increased the specific incision activity of mouse liver and brain extracts by 
354 decreasing the non-specific endonuclease activity in the BER assay [40], but did not have such 
355 an effect in mouse colon and lung [41]. To reduce non-specific incision activity in mouse colon 
356 and lung the protein concentration of extracts had to be decreased or additional washes 
357 during extraction had to be performed [41].
358 The reproducibility or inter-experimental variability of the assay has also been demonstrated 
359 for different types of samples (lymphocytes and colon biopsies) for both the in vitro BER and in 
360 vitro NER assay by analysing duplicate samples on different days [29, 31, 32, 36]. This indicates 
361 that the repair activity is stable after storage of samples. Similarly, long-term preservation of 
362 animal tissues and extracts to be used in the in vitro DNA repair assays has been demonstrated 
363 for BER [40]. Regarding the NER assay, the situation depends on the storage of the sample; 
364 either as cell pellet or protein extract, plus the addition of ATP to the extract. The use of ATP or 
365 an ATP-regenerating system in the extract is not needed when the BER assay is carried out in 
366 lymphocytes [29]. When assessing NER incision activity similar results have been obtained with 
367 or without adding ATP to freshly prepared cell extracts [31, 32], demonstrating that samples 
368 contain enough ATP to carry out the first reactions of the repair process. However, Langie et 
12
369 al. showed that protein extracts lose their activity after long-term storage (i.e. several weeks) 
370 at -80°C and that activity is restored by adding ATP [31]. Cell pellets stored at -20°C kept their 
371 activity for at least 40 days and the addition of ATP did not increase activity [31]. Some authors 
372 claim that magnesium is essential for the detection of NER activity [32].  However, it is 
373 advisable to test this for each new cell type or tissue under study, as a too high magnesium 
374 concentration in the extract could enhance non-specific nuclease activity, as demonstrated in 
375 the BER assay when using mouse tissue extracts [40, 41]. 
376
377 2.3 Crucial parameters to consider 
378 The incubation time of the extract with the substrate is a critical parameter of the assay; time-
379 course experiments showed an initial linear increase in SBs followed by a plateau [29]. The 
380 optimal time of incubation should be selected from the linear part of the curve, but showing a 
381 high enough BER or NER incision activity. Several incubation times have been reported, many 
382 of them based on preliminary studies [31, 39, 40]. These variations in incubation times could 
383 be partially due to the different adopted incubation methods; some researchers use humid 
384 boxes placed in an incubator, while others use a 'slide moat'. It is crucial to select an 
385 incubation time which detects enzyme or extract activity in the linear phase of the titration 
386 curve, not to reach the plateau.  
387 Langie et al., studied the effect of varying the agarose concentration in the BER assay; the 
388 agarose concentration may affect the penetration of the enzyme and in consequence the 
389 incision repair activity of, in this case, mouse liver extracts [40]. Indeed, an inter-laboratory 
390 comparison was published in 2013 [46], in which the incubation step of the nucleoids with the 
391 repair extract seemed to be an important stage in the protocol that led to large inter-
392 laboratory variation. In this trial, 8 laboratories tested the BER activity of three cell lines 
393 starting with cell pellets or with cell extracts, both provided by the coordinating laboratory. 
394 The 6 most experienced laboratories reported the same cell line as having the highest activity. 
395 A significant correlation was reported between the repair activity found when testing the 
396 provided extract and the self-made extract from the provided cell pellet; this suggests that the 
397 predominant source for inter-laboratory variation was the incubation of the extract with the 
398 substrate. Though detailed instructions were given to prepare the cell extract or to assess the 
399 repair activity of the provided and self-made extracts, each laboratory used their own 
400 conditions for the comet assay. Therefore, more attention should be given to standardize this 
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401 particular steps (i.e., agarose concentration and extract incubation) and the penetration of 
402 repair enzymes into the gel.
403
404 2.4. Outstanding issues that warrant further technical investigation
405 In the protocol published by Azqueta et al., some outstanding technical issues were noted [34]. 
406 These and additional technical issues are outlined below: 
407 1) DNA incision activity can be studied in relation to the number of cells in the extract, the 
408 protein concentration or the DNA content, but the accuracy of the different options has not 
409 been studied. 
410 2) Although, aphidicolin is mainly known as a DNA polymerase inhibitor, the use of aphidicolin 
411 in cell extracts also prevents the occurrence of non-specific nuclease activity in the BER assay 
412 [40]. Aphidicolin was described to have an inhibitory effect on various nucleases that do not 
413 have a specific role in DNA repair processes. However, its effect when the NER assay is carried 
414 out has only been tested once with human colon biopsies [36]. In some cases, it may enhance 
415 the detection of NER activity by preventing repair synthesis [40].
416 3) There is a lack of proportionality between repair activity and protein concentration, which 
417 needs to be further investigated. Meanwhile, it is recommended that as far as possible extracts 
418 should be made from the same number of cells or the same wet weight of tissue, and resulting 
419 protein concentrations should be checked.
420 4) The in vitro repair assay needs to be validated by comparison with other in vitro assays. 
421 Some efforts have been made in this direction as is stated in the next section.
422 5) A new ‘ring study’ involving several laboratories, standard cell extracts and standard 
423 protocols should be carried out. 
424 6) The most widely used substrate for the in vitro repair assay has been Ro19-8022 + light. 
425 However, potassium bromate is an easier and cheaper chemical to use. This substrate has 
426 been used for repair activity in cell cultures [47] and human biomonitoring studies [30]. 
427 Interestingly, potassium bromate generates equally high levels of DNA lesions detectable in 
428 the hOGG1- and Fpg-modified comet assay, whereas Ro19-8022 + light seems to generate 
429 lower levels of hOGG1-sensitive sites as compared to Fpg-sensitive sites [48]. This discrepancy 
430 remains to be investigated.  
431 7) For the NER assay, both UV light and BPDE have been used to produce substrate nucleoids, 
432 and the relationship between the two has not been properly studied; cyclobutane pyrimidine 
14
433 dimers and bulky DNA adducts are not necessarily recognised in the same way by repair 
434 enzymes.
435 8) It has not been studied so far whether the use of different cell types to produce the 
436 substrates (e.g. different established cell lines or human lymphocytes) has any influence on the 
437 measurement of DNA repair.   
438 9) There is a lack of true positive controls: i.e., compound that increases the cellular repair for 
439 the cellular repair assay, or extracts with a high repair activity for the in vitro repair assay. This 
440 may be a complicated issue since the induction/modulation of the DNA repair may depends on 
441 the cells line/tissue under study. However, some attention should be given to this point. Over 
442 recent years, different versions of the alkaline comet assay have been developed in order to 
443 increase the throughput. For example, a medium throughput comet assay has been 
444 successfully used in an updated version of the in vitro BER and in vitro NER repair assays, using 
445 12 minigels on microscope slides [34, 36, 49], or 8 deposits on GelBond® films for the 
446 Aphidicolin-block cellular repair assay [50, 51]. More recently, further adaptations enable high 
447 throughput performance of the comet assay. For example, the use of larger Gelbond® films 
448 and reduction of the volume of agarose deposited offer the possibility to increase to 96 
449 minigels processed on the same support [52], but this method has not yet been applied to the 
450 repair assays. Other technologies derived from the comet assay, using high throughput 
451 microarray or microfluidic approaches, have been proposed to study DNA damage, for 
452 example CometChip [53], Microfluidic Comet Array [54] and HaloChip [55]. These techniques 
453 have been applied to the cellular repair assay, but to date they are not applicable to the in 
454 vitro repair assay, either for NER or for BER.
455 High throughput is crucial for human biomonitoring to allow the processing of a high number 
456 of samples. A new challenge is to adapt either the high throughput comet assay or one of the 
457 newer derived technologies in order to make it useful not only for the cellular repair assay but 
458 also for the in vitro DNA repair assays.
459
460 3. Comparison of techniques and comparison BER/NER
461 Comparing techniques with each other, preferably comparing a newly developed assay with a 
462 gold standard, is a crucial aspect of the validation of a technique, because it provides 
463 information about the extent to which the method actually measures the intended outcome 
464 (in this case DNA repair activity). Several studies have performed various assays in parallel, but 
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465 the correlations between the outputs of these assays are rarely described. In this section, we 
466 describe the various comparisons that have been investigated to date.
467 A few reports compared data from the comet-based cellular repair assay against plasmid-
468 based repair assays to study BER. Astley et al. (2002) observed an increase in the removal of 
469 H2O2-induced SBs in carotenoid-supplemented Molt-17 cells by the cellular repair assay, but 
470 were unable to confirm these data by means of DNA repair patch plasmid synthesis assays 
471 [56].  
472 Incubation of H2O2-treated HeLa and Caco-2 cells with -cryptoxanthin, a common carotenoid, 
473 led to a ~2-fold increase in the rate of removal of oxidised purines by BER in the cellular repair 
474 assay. This effect was confirmed with the in vitro BER assay; incision activity was about twice 
475 as high with the extract prepared from carotenoid pre-incubated cells [57]. Ramos et al. (2010) 
476 showed that water extracts from the Salvia species Salvia officinalis and Salvia fruticose, and 
477 the polyphenolic compound luteolin-7-glucoside increased the rate of H2O2-induced DNA SB 
478 removal in Caco-2 cells [58]. Similarly, pre-incubation for 24 h with extracts of Salvia Officinalis 
479 and luteolin-7-glucoside increased BER-related incision activity in Caco-2 cells. The same group 
480 observed the triterpenoid ursolic acid and the flavonoid luteolin (two compounds present in 
481 fruits and vegetables) to enhance the H2O2-induced SBs removal rate and BER-related incision 
482 activity in pre-treated Caco-2 cells [59].
483 Although BER has been studied the most, several studies also use the in vitro DNA repair assay 
484 to study NER in humans [31, 32, 35, 36, 60-62], as well as in cell lines [63, 64], and in animal 
485 models [65, 66]. However, as far as we know, only one study reported a correlation of the in 
486 vitro NER assay with another functional DNA repair method, i.e. BPDE–DNA adduct removal 
487 over 48 hours as determined by 32P-post-labelling [31]. The slopes of the BPDE-DNA adduct 
488 removal curves, were plotted against the DNA incision activity values as measured by the in 
489 vitro NER assay on substrates containing BPDE-DNA lesions, and showed a significant positive 
490 correlation between the two assays (linear regression: R2=0.76).
491 Although NER can act as a back-up mechanism for BER in situations of massive oxidative stress 
492 paired with high levels of damaged DNA [67-69], these two repair mechanisms are not always 
493 affected in the same way by external factors or disease conditions. In a study of seventy 
494 patients with sporadic colorectal cancer, BER and NER activities showed a significant positive 
495 correlation in healthy colon epithelium (Pearson test: R=0.32) [35]. In contrast, Gaivao et al. 
496 (2009) did not observe a statistically significant correlation between BER and NER activity in 
497 lymphocytes of healthy volunteers [32]. Still, a direct comparison of NER and BER activity is not 
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498 necessarily informative, because they recognize and repair different types of DNA lesions. In 
499 some cases, NER and BER can even be modulated in opposite directions. For instance, Brevik et 
500 al. (2011) observed that BER and NER activities were affected in the opposite way by kiwi fruit 
501 and phytochemical consumption (i.e. high intake of a variety of antioxidant-rich plant 
502 products) [62]. In addition, storage of blood samples at room temperature for 24h reduced 
503 NER activity as assessed by the aphidicolin-block cellular repair assay for NER compared to 
504 fresh samples, whereas OGG1 activity (representing BER) was higher after 24h storage at room 
505 temperature versus freshly isolated samples [50].
506 Overall, both the cellular repair assay and in vitro repair assays have proven to be useful and 
507 sensitive for studying the modulation of DNA repair by nutritional factors, environmental 
508 exposures and disease state (also see section 4). We are convinced that new comet-based 
509 repair assays to study additional repair pathways are bound to come in the near future. It will 
510 be of utmost importance to include comparisons with available functional DNA repair assays 
511 into their validation process.
512
513 4. Inter- and intra-individual variation in DNA repair activity 
514 Variations in DNA repair activity at the level of the individual are poorly investigated. However, 
515 it is important to understand the sources of variation. There is currently insufficient knowledge 
516 to conclude to what extent the repair activity of an individual is determined by genetics, or 
517 whether it can be influenced by environmental factors. Moreover, variation between 
518 individuals in both BER and NER activities cannot be explained. 
519 Gaivao et al. measured DNA repair activity on several occasions in the course of a nutritional 
520 intervention study, involving 30 healthy subjects [32]. Both BER and NER were assessed by 
521 applying the in vitro repair assay. As the intervention appeared to have no effect on the DNA 
522 repair activity, data from the six blood samplings - at 4-week intervals – were used to examine 
523 both inter- and intra-individual variation. In Table 2, the correlation coefficients for all 
524 timepoint comparisons are shown, for both BER and NER separately. In 9 of the 15 
525 comparisons of BER rates, the correlation was statistically significant, and this was true for 12 
526 out of 15 comparisons of NER rates. It is interesting that the correlation coefficients did not 
527 decrease as the time between samplings increased. Thus, although there may be unknown 
528 factors that affect repair activity from time to time, there is an underlying consistency, in both 
529 BER and NER, for a given individual. While there was considerable inter-individual variation in 
530 both BER and NER activity between subjects (coefficients of variation: 32% and 59% 
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531 respectively), the range between highest and lowest activity was substantially higher for NER. 
532 Figure 3 shows, as examples, two of the timepoint comparisons for BER and NER. Although it 
533 illustrates the relative consistancy of repair rates for individuals, the figure also shows the 
534 variety of repair rates between individuals. For BER, most subjects have rates within a 3-fold 
535 range; for NER (using UV-exposed substrates in the repair assay), the range is about 7-fold. 
536 This is in line with a previously reported 10-fold difference in NER activity using BPDE-exposed 
537 substrates in the repair assay  [31]. Interestingly both studies [31, 32], reported that some 
538 individuals seem to have negligible repair activity. Whether this has any health implications is 
539 unclear. It is possible that a low NER rate indicates a reduced intrinsic capacity to deal with UV-
540 induced cyclobutane pyrimidine dimers or bulky adducts, or it could be that individuals with 
541 low measured NER activities are not exposed to DNA damage and therefore their repair 
542 enzymes are simply not induced. 
543 Similarly, in a group of 122 subjects (mean age 24.5 y, range 19-48 y, 39 men and 83 women), 
544 inter-individual variation in NER activity assessed by the aphidicolin-block cellular repair assay 
545 in response to BPDE, ranged from 0.66 to 26.14 %DNA in tail (mean 7.38 +/- 4.99 %), showing 
546 an almost 40-fold difference across the group [51].
547 There are some other publications comparing repair rates between individuals using different 
548 techniques (Table 3). These studies highlight considerable inter-individual variability in the 
549 capacity to repair DNA. Certain factors, such as age and sex, might affect repair activity and 
550 recognising such factors would be necessary for the design of human studies and 
551 interpretation of repair data from such a trial. The following sections therefore describe which 
552 factors, whether host factors (e.g., age, sex and genetic polymorphisms in DNA repair genes) 
553 or environmental/lifestyle factors (i.e., smoking, status, diet and health status), may contribute 
554 significantly to this variability.
555
556 4.1. Host factors
557 Age and sex:
558 Numerous studies have reported a strong positive link between increasing age, DNA damage 
559 and defective repair [40, 41, 74-81]. However, to date few human biomonitoring studies using 
560 the comet assay have established the relationship between aging and repair activity (table 4).
561 In one study of 375 participants with occupational exposure to asbestos, stone wool and glass 
562 fibre, increasing age was associated with increasing DNA BER activity measured by the in vitro 
563 DNA repair assay using Ro19-8022 with light to induce damage in substrate cells (Correlation 
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564 coefficient R=0.1) [69]. In contrast, in a study of 244 men and women (mean age 41.3), neither 
565 BER of oxidative damage (in vitro repair assay) nor irradiation-induced repair (cellular comet 
566 assay) was affected by either age or sex [83]. A cross-sectional study of subjects from Denmark 
567 showed an inverse association between age (18 to 83 years) and BER activity (using KBrO3 
568 treated cells as substrate) in PBMCs; the effect was stronger in women as compared to men 
569 [30]. However, in a study specifically designed to assess the impact of age on DNA repair 
570 activity, Humphreys et al., investigated the relationship between age and BER activity 
571 measured by the in vitro repair comet assay using Ro19-8022 + light damaged substrate cells 
572 [82]. BER was investigated in 3 groups of subjects of increasing age [20-35 y (n-40), 63-70 y 
573 (n=35) and 75-82 y (n=22)]. Here, the authors found a positive but weak correlation between 
574 age and BER rate (r=0.25). However, it should be mentioned that the authors of this paper 
575 state that the inclusion criteria were “relaxed” for the oldest group. Consequently, subjects 
576 with disease in the oldest group might have biased the results. DNA repair activity was the 
577 same in both sexes. 
578 The relationship between age and DNA repair may be further complicated by differences in 
579 repair activity in different strata of population studies defined by sex or race. Trzeciak et al. 
580 (2008) used a cellular repair assay to study the impact of these factors on repair of -radiation-
581 induced DNA damage in PBMCs from four age-matched groups of male and female whites and 
582 African-Americans between ages 30 and 64 [84]. They reported a positive association between 
583 repair activity and age in white females, but a statistically non-significant decrease in African-
584 American females.
585 Overall, the available data suggest that, while sex is not a major contributor to inter-individual 
586 variation in repair activity, age is a factor that should be taken into account (for example, by 
587 ensuring a similar age distribution in control and test groups) - though as yet there is no 
588 indication of a major positive or negative effect. Also animal studies have reported conflicting 
589 results. There are recent reports that the effect of age on BER activity (in vitro repair assay) can 
590 be tissue dependent and that the brain seems to be the most vulnerable for a decline in BER 
591 activity with age [40-42, 74]. Future human biomonitoring studies should consider studying 
592 DNA repair in other available tissues with different cell turnover, in comparison with blood 
593 cells (e.g. buccal cells, saliva, colon biopsies, etc.). The effect of race on repair activity and its 
594 interaction with age is unclear.
595
596 Genetics (polymorphisms in DNA repair genes)
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597 Data from human biomonitoring studies, using the comet assay to assess the associations 
598 between genetic variations in DNA repair genes and repair activity are scarce. Vodicka et al. 
599 performed a relatively large-scale study [244 healthy subjects, 183 men and 61 women, mean 
600 age 41 ± 11 y], specifically designed to investigate the impact of various genotypes (XRCC1, 
601 APE1, hOGG1, XPD, XPG, XPC, XRCC3 and NBS1) on NER and BER activities. BER (in vitro DNA 
602 repair assay) was significantly lower in people homozygous for the GG variant of hOGG1 
603 compared with carriers of the normal genotype [83]. The ability to repair -irradiation damage 
604 (cellular repair assay) was significantly lower in individuals homozygous for the XRCC1 AG 
605 genotype. However, in a study by Jensen et al., healthy subjects did not show any difference in 
606 BER activity (in vitro repair assay using Ro19-8022 + light as substrate) associated with the 
607 hOGG1 Ser326Cys polymorphism; 49 subjects of each genotype were selected and group-
608 matched from a cross-sectional study of 1019 subjects [85]. Interestingly, there are indications 
609 for an interplay between BER and NER, or NER playing a role as a back-up mechanism for BER. 
610 For instance, a study on occupational exposure to potential genotoxic agents, observed BER 
611 activity (using the in vitro DNA repair assay) to be significantly higher in subjects carrying the 
612 XPA AA normal genotype compared to the AG and GG variants [69]. 
613 In addition a few studies have investigated the gene-environment interactions. In a study of 36 
614 volunteers recruited to explore the impact of nutrient/gene interactions on NER activity (in 
615 vitro DNA repair assay using BPDE-DNA as substrate), subjects were grouped according to 
616 genetic polymorphisms in several NER genes (XPA, XPC, ERCC1, ERCC2, ERCC5, ERCC6, and 
617 RAD23B; [60]). Here, NER activity was significantly lower in subjects who carried a relatively 
618 large number of “low” NER activity alleles. The XPA G23A gene was the strongest predictor for 
619 NER activity, with individuals homozygous for the recessive AA variant of the gene 
620 demonstrating 3-fold lower repair activity compared to the normal genotype. Interestingly, 
621 this same XPA 23A allele was observed to be associated with lower BER activity (in vitro DNA 
622 repair assay) in colonic tumour tissues, but not in the adjacent healthy tissue [36]. A recent 
623 study investigated the impact of genetic polymorphisms on BER repair activity in 43 patients 
624 with recurrent depression disorders and 59 controls without disease [86]. The study included 
625 12 polymorphisms in 4 key BER genes (hOGG1, MUTYH, PARP1, and LIG3), which were linked 
626 to the cellular repair activity on H2O2-induced SBs, but it should be noted that the sample size 
627 reported here is small for a study investigating the influence of genotype on disease risk.
628
629 4.2 Lifestyle factors
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630 Cigarette smoking
631 Although, a meta-analysis (evaluating 38 studies) indicated higher levels of DNA damage in 
632 smokers versus non-smokers [87], information on the effect of cigarette smoking on DNA 
633 repair activity is conflicting. SB re-ligation activity in leukocytes following -irradiation (10 Gy) 
634 (using the cellular repair assay), was higher in current cigarette smokers (n=17), compared 
635 with non or ex-smokers (n=23) [88]. Similarly, SB re-ligation activity following exposure to -
636 irradiation (5 Gy)  was elevated in smokers (n=80, 1.05 ± 0.81 SSB/109 Da) compared with non-
637 smokers (n=134, 0.77 ± 0.62 SSB/109 Da) [83]. However, in this study, BER (in vitro repair 
638 assay) was not affected by smoking. BER measured using the in vitro DNA repair assay was 
639 significantly lower in poorly nourished male smokers (n=46, mean age 39 y) compared to well-
640 nourished males and females (n=39, mean age 27 y), with mean incision activity 65.9 AU (95% 
641 CI 60.4, 70.0) in smokers compared with 86.1 AU (95% CI 76.2, 99.9) in healthy subjects. 
642 Moreover, repair data from the cigarette smokers were substantially less variable within the 
643 group when compared with the non-smoking participants (range 30-100 AU and 10 -180 AU in 
644 the smoking versus the non-smoking subjects respectively). The same authors also studied the 
645 effect of smoking in a cohort of workers in a tire plant by performing the cellular repair assay 
646 and the in vitro BER assay [89]. Higher rates of repair of irradiation-induced DNA damage were 
647 detected in smokers versus nonsmokers, but this was not confirmed by the in vitro BER assay 
648 with Ro19-8022+light generated substrate.   
649
650 Dietary factors 
651 The comet assay has been used widely in human biomonitoring to assess both the impact of 
652 whole foods (e.g. fruits and vegetables) and specific nutrients (phytophenols, antioxidants and 
653 folic acid) on genomic instability, particularly the impact of diet on DNA SSBs and altered DNA 
654 bases (e.g. oxidative, alkylation and misincorporated uracil). In addition, several studies have 
655 described how nutrition modifies DNA repair activity (Table 5). 
656 After the in vitro DNA repair assay came into use in 2001, several researchers started 
657 performing it in parallel to the cellular repair assay. Cellular extracts from human lymphocytes 
658 showed a markedly higher DNA repair incision activity after a single oral dose of 100 mg 
659 CoQ10/day for 1 week compared to controls (~3-fold increase in CoQ10 group) as detected by 
660 the in vitro BER assay [92]. Similarly, the cellular repair assay, studying the removal of Ro 19-
661 8022 + light induced oxidative lesions, detected a statistically significant ~2-fold higher rate of 
662 DNA damage removal in CoQ10 supplemented lymphocytes compared to the control group. In 
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663 a small randomised cross-over design study, subjects consuming between 1 and 3 kiwi fruits 
664 daily for 3 weeks significantly increased in vitro BER activity (Ro19-8022+light damaged 
665 substrate cells) in PBMCs from male (n=6) and female (n = 8) healthy participants (26-54 y of 
666 age) [93]. Volunteers who consumed 3 kiwi fruits each day showed a significantly elevated 
667 plasma vitamin C level and substantially enhanced BER activity compared with pre-
668 supplementation levels (>60%). Supplementation also increased the resistance of isolated 
669 PBMCs to oxidative damage and was associated with reduced DNA SBs and oxidised base 
670 damage (Fpg-sensitive sites). In contrast, there was no correlation between individual BER 
671 rates and markers of DNA damage. A significant association between BER activity, assessed by 
672 the in vitro DNA repair assay (Ro19-8022+ light damaged substrate cells) and antioxidant 
673 status was described subsequently, with elevated plasma lutein/zeaxanthin correlating with 
674 high BER activity [82]. Supplementation with carotenoids for three weeks, showed enhanced 
675 re-ligation of H2O2-induced SBs and increased DNA repair patch synthesis activity compared to 
676 their initial repair activity before the 3-week intervention [94]. Similarly, supplementing male 
677 smokers (n=46, mean age 39) with slow release vitamin C (500 mg/day) and vitamin E (182 
678 mg/day) was found to significantly increase BER (in vitro repair assay) by approx. 27% (95% CI 
679 12 – 41%) after 4 weeks [39]. Inter-individual variation in incision activity was generally 
680 consistent within this group (range 30-100 AU). In contrast, feeding healthy subjects (n=43 
681 men and women, mean age 27 y) 600 g of fruits and vegetables, or the equivalent levels of 
682 antioxidant vitamins and minerals as a supplement for 24 d, did not change BER activity 
683 measured by the same group and using the same assay [39]. Inter-individual variability in 
684 incision activity was substantial, ranging from less than 10 to more than 180 AU, with a mean 
685 of 86.1 AU (95% CI 76.2 - 99.9). 
686 In a more recent study, feeding male smokers (45-75 y) a diet high in antioxidant-rich fruits 
687 and vegetables (n=33) or 3 kiwifruits per day (n=33) for 8 weeks significantly increased total 
688 antioxidant levels (2-fold), plasma vitamin C, β-carotene and tocopherol, compared to the 
689 control group (n=34). Also BER activity was increased 40% (n=23) and 29% (n=25) upon 
690 antioxidant-rich fruits/vegetable or kiwi consumption, respectively) (measured using the in 
691 vitro DNA repair assay) [62]. Surprisingly, NER activity (in vitro repair assay and UVC radiation 
692 for substrate), was significantly decreased (39% (n=13) and 38% (n=11); upon antioxidant-rich 
693 fruits/vegetable or kiwi consumption, respectively). In contrast, feeding young male smokers 
694 steamed broccoli (250mg/day for 10 days) did not alter BER activity (in vitro repair assay; [91]). 
695 A similar lack of effect of antioxidant supplementation on BER (in vitro repair assay) has also 
696 been described in 48 young healthy volunteers given 100 µg selenium, 450 µg vitamin A, 90 mg 
22
697 vitamin C and 30 mg vitamin E supplements for 6 weeks [71]. Inter-individual BER activity was 
698 substantially different between the volunteers (41-fold). NER (using the in vitro repair assay 
699 with BPDE-DNA as substrate) was also found to be unaffected by supplementing healthy 
700 participants (114 female and 54 male subjects aged between 18 and 45 y) flavonoid-rich 
701 blueberry and apple juice (1L/day) for 4 weeks [60]. In this study inter-individual variation, 
702 while considerable, was maintained across the two sampling periods (correlation: R=0.69).
703 While the majority of studies report the impact of food or supplements rich in dietary 
704 antioxidants on DNA repair activity, a few studies have investigated the impact of other key 
705 dietary agents. Low intake of folate is associated with an increased risk of several human 
706 cancers, particularly colon cancer [95]. Numerous studies have reported that folate deficiency 
707 induces genomic instability and malignant transformation in vitro, in animals and in human 
708 studies [95]. In a relatively large-scale, randomised double blind-placebo controlled 
709 intervention study, participants (n=61, 20-60 y of age, male and female non-smokers and non-
710 supplement users) were given 1.2 mg folic acid daily for 12 weeks to investigate whether 
711 enhancing folate status could improve markers of genomic stability, including BER incision 
712 activity measured using the in vitro DNA repair assay [90]. BER incision activity was similar 
713 across both intervention groups prior to supplementation, with a median value in both 
714 treatment groups of 63 AU, extending from 34 and 93 AU (2.5 fold range). While there was no 
715 association between red cell folate status and BER activity at the start of the study, increasing 
716 folate intake resulted in significantly decreased BER in those volunteers with the lowest pre-
717 intervention folate levels, indicating that BER can be modulated by folate status. 
718 These studies highlight that diet (and supplement use), has a significant influence on DNA 
719 repair activity. The impact of other common nutrients and non-nutrients (such as alcohol and 
720 caffeine), as well as other lifestyle factors (including physical activity) on inter-individual 
721 variation in DNA repair activity measured using the comet assay remains largely unknown and 
722 therefore deserves further attention. 
723
724 Health status
725 The comet assay has been used widely to determine the relationship between DNA damage 
726 (as a marker of genome instability) and various diseases including cancer, vascular disease, 
727 diabetes and inflammation.  [96] [97] [98] [99]. However, only a few studies to date have 
728 investigated the impact of health status (particularly malignant transformation) on NER activity 
729 using the comet assay. 
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730 Palyvoda et al., measured NER repair of -radiation-induced (2 Gy) DNA SBs in lymphocytes 
731 isolated from 44 healthy donors and 38 patients with squamous cell carcinoma of the head 
732 and neck (SCCHN), prior to treatment [100]. The cellular repair assay, following a time course 
733 of repair post-irradiation (0-180 min), was used to measure endogenous DNA SBs, radiation-
734 induced damage, rate of repair and residual or non-repaired damage in isolated lymphocytes 
735 cultured for 24 h prior to treatment. Endogenous DNA SBs was almost 3-fold higher in patients 
736 with SCCHN compared with healthy subjects (median 90.3 vs 33.3 AU respectively), with 
737 significantly more individuals in the cancer group showing a high level of damage. Overall, NER 
738 repair rates were not significantly different between participants with and without cancer, due 
739 to substantial variation in measured repair activity across all individuals. However, by 
740 stratifying individuals into subjects with high endogenous DNA SBs, high induced DNA damage, 
741 low NER rate and high residual DNA damage, a significantly higher proportion of cancer cases 
742 displayed this “negative phenotype” compared with healthy participants (39.4% vs. 7.3% 
743 respectively). The variation in DNA damage and repair in this study was substantial, making it 
744 difficult to draw strong conclusions. It is also important to note that cases and controls were 
745 not matched in this study, and that age, sex and cigarette smoking status were markedly 
746 different between the two groups. A significant association between cancer incidence and low 
747 NER rate was observed in a smaller study of SCCHN cases (n=12) and healthy donors (n=15), in 
748 this case matched for age, sex and cigarette smoking [88]. Whole blood was used to measure 
749 DNA damage and repair following -irradiation (10Gy) using the cellular comet assay, without 
750 pre-culture, and assessing percentage tail DNA using computerised image analysis. Here, DNA 
751 repair activity was significantly lower in patients with SCCHN cancers relative to controls 
752 (46.5% v 36.8% respectively).
753 How other human pathologies and effectors of health and disease, such as low-grade 
754 sustained inflammation [101], affect individual variation in DNA repair activity is essentially 
755 unidentified and represents a substantial gap in knowledge. In any case, the studies so far 
756 reported, have been case-control studies and it is not possible to discern whether a difference 
757 in repair activity is a cause or an effect of the disease (or possibly an effect of treatment). What 
758 is really needed is a prospective study, i.e. a large cohort of healthy subjects whose repair 
759 activities are measured and who are then followed up for a long enough period of time for 
760 disease to develop and be recorded. 
761
762 4.3. General comment on individual variation in DNA repair
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763 The studies reviewed above show that age, sex, health status, diet, and other lifestyle factors 
764 such as smoking, impact to some extent on DNA repair (BER and NER) activity and contribute 
765 substantially to the significant inter-individual variation in repair rates described in numerous 
766 human studies. It should also be noted that large assay variation may be interpreted wrongly 
767 as inter-individual or intra-individual variation. However, if intra-individual variation (estimated 
768 from repeat measurements on different occasions) appears to be at a low level, assay variation 
769 can be discounted. There is a need for controlled studies that systematically assess inter-, 
770 intra- individual and assay variation in for instance ring-trials. One approach would be similar 
771 to the ECVAG ring trials on DNA damage endpoints, in which contributors to the overall 
772 variation were assessed in a systematic manner [102-105]. 
773 Host factors such as age and sex, and certain anthropometric characteristics such as body mass 
774 index can be relatively easily dealt with by carefully matching control and test groups. 
775 Adjusting for other factors, such as single nucleotide polymorphisms in DNA repair genes is 
776 more difficult, principally due to the requirement for substantially larger numbers of 
777 participants to adequately power these biomonitoring studies. Genetic variation in DNA repair 
778 genes can also be included in intervention studies as effect modifiers [60]. While specific 
779 dietary items obviously have an effect on repair activity, as discussed above and reviewed 
780 before [106], it is difficult due to lack of information to estimate the impact of other lifestyle 
781 factors such as physical activity, sunlight exposure, drug use and health status on inter-
782 individual variation in DNA repair activity. The advantage of studying DNA repair as phenotypic 
783 marker rather than single nucleotide polymorphisms or gene expression is that the latter do 
784 not take into account epigenetic and post-transcriptional modifications that can affect the final 
785 DNA repair activity. 
786
787 5. Repair activity kinetics and timing 
788 No studies have specifically assessed DNA repair kinetics in a time-course investigation in 
789 humans, using multiple sampling over a short period of time. Assessing DNA repair kinetics is 
790 important for selecting optimal sampling times relative to exposure. For instance, if exposure 
791 to DNA damaging compounds induces DNA repair, a measurement shortly after exposure will 
792 indicate higher levels of repair. On the other hand, after a longer period of time when damage 
793 has again decreased due to DNA repair or cell death, such an increase in DNA repair activity 
794 may no longer be detectable. Unfortunately, most of the information on DNA repair kinetics 
795 originates from biomonitoring studies using the in vitro DNA repair assay, assessing DNA repair 
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796 in samples that have been obtained at a single time-point before, during or after a change in 
797 exposure.  
798 Only one study has investigated the effect of short-term phytochemical supplementation on 
799 repair activity. Intake of green tea was associated with increased BER activity in lymphocytes 
800 that were obtained 60 and 120 min after drinking 200 mL of freshly prepared tea [107]. 
801 Although this study suggests that changes in DNA repair activity after a particular exposure can 
802 be very quick (minutes to hours), most studies that investigated dietary interventions actually 
803 studied the changes over a period of several days to weeks (see paragraph 4.2). Regarding 
804 green tea consumption,  12 weeks of regular green tea consumption indeed significantly 
805 increased in vitro BER activity toward Ro19-8022 + light generated DNA damage in 
806 lymphocytes [108], but the study by Ho et al. (2014) [107] suggests that this change could 
807 already have been detected at much earlier time points. Time points chosen for sampling in 
808 other dietary interventions with in vitro BER or NER activity as endpoint vary between 1 to 8 
809 weeks [92, 62, 71, 93], with reported washout periods between 1 and 2 weeks [92, 93]. 
810 Interpretation may become more complex if the intervention is performed in smoking 
811 individuals, because smoking by itself may already affect BER or NER activity [39, 91] (see 
812 paragraph 4.2). 
813 It is a matter of debate how the activity of hOGG1 in human cells is regulated, as the OGG1 
814 gene may be constitutively expressed [28]. Presence of DNA damage seems logical as an 
815 inducer of DNA repair. Indeed, animal studies show that DNA repair can be induced by specific 
816 DNA damaging triggers and that alterations in repair activity are relatively quick (within days) 
817 [65]. In in vitro studies with cell lines, induction of BER or NER can occur within hours [58, 59, 
818 101, 109]. The number of investigations in which changes in DNA repair were studied after a 
819 specific exposure of humans is limited: A study with controlled exposure to wood smoke, 
820 although statistically underpowered, showed a slightly increased in vitro BER activity and 
821 increased urinary 8-oxoGua (i.e. repair product of hOGG1) at 20 h post-exposure [110]. 
822 Another short-term study reported increased levels of oxidatively damaged DNA and unaltered 
823 BER activity in PBMCs after 6 or 24 h controlled exposure to traffic-related air pollution [111]. 
824 Likewise, oral exposure to nanomaterials showed increased levels of oxidatively damaged DNA 
825 in the liver of rats at 24 h post-exposure, whereas the in vitro BER activity to Ro19-8022 + light 
826 generated DNA substrate cells was unaltered [112]. 
827 To summarise, BER and NER kinetics have not been well investigated in humans and animals. 
828 There are inconsistent reports of altered BER activity after dietary interventions and particle 
829 exposure, but sampling times are not frequent enough to draw any conclusions on the time 
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830 frame in which the changes occur. There are currently too few studies on NER activity to 
831 speculate about timing of sampling for assessment of changes in repair activity. From the 
832 available literature, it is not possible to suggest an optimal time of sampling in relation to 
833 exposure for the assessment of BER and NER activity. Therefore, to improve the applicability of 
834 DNA repair measurements in human biomonitoring, it is essential to perform studies in which 
835 repair activity is assessed at various time points after exposure/ intervention.
836
837 6. Surrogate vs. target tissues 
838 PBMCs (frequently referred to as lymphocytes) are extensively used to measure DNA repair 
839 activity in human biomonitoring studies. They circulate through the whole body and are 
840 regarded as sentinel cells since they can have a relatively long life-span [113]. Moreover, they 
841 are easily obtained, available in large numbers and easy to handle and culture if necessary. The 
842 purity of the cells fraction is normally not specified and a mixture is probably the most 
843 commonly used material. While they are convenient as surrogate cells, circulating blood cells 
844 are not the target for carcinogenesis, and the response of these cell types does not necessarily 
845 mimic the effect in true target tissue cells. Also, confounding factors (e.g., smoking, diet, 
846 medication, air pollution, exercise) should be taken into account [33, 114], because the 
847 reaction of surrogate cells in the exposure-outcome relationship may be different in target 
848 organ cells. However, using white blood cells is relatively non-invasive and they are the 
849 surrogate cells of choice in studies where (as is usually the case) the target tissue is not readily 
850 attainable [115]. 
851 There are only 3 studies with humans in which tissues other than lymphocytes or PBMCs have 
852 been used to measure DNA repair activity by the comet assay [33, 35, 36]. In these studies, 
853 DNA repair activity was measured in colon biopsies and two of these assessed the correlation 
854 between DNA repair activity in tissues and PBMCs. 
855 Herrera et al. observed that DNA cross-link repair activities of colon tumour epithelial cells and 
856 lymphocytes from colon cancer patients (using the in vitro repair assay) were not correlated. 
857 Thus, lymphocytes were not predictive for the repair ability of the tumour [33]. Slyskova et al. 
858 found a positive correlation in BER and NER activity between PBMCs and healthy colon tissues, 
859 but not between PBMCs and colon tumour tissues [35]. More studies are needed to draw 
860 conclusions about the suitability of using lymphocytes or PBMCs to reflect the DNA repair 
861 activity of healthy target organs. However, studies in which biopsies of organs from healthy 
862 people are included are difficult to perform.  
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863 Epithelial cells, as specialized components of many organs, have the potential of being an 
864 attractive bio-matrix to evaluate the DNA repair activity of individuals. Examples of possible 
865 sources of exfoliated epithelial cells in human biomonitoring studies are presented in Table 6. 
866 Unfortunately, although there are many studies that use the comet assay to measure DNA 
867 damage in buccal, nasal, tear duct, lens and corneal epithelial cells [116], DNA repair activity 
868 has never been explored in these biological matrices using the comet assay. Most of these cell 
869 types, while not necessarily target cells for carcinogenesis, have the distinct feature of coming 
870 into direct contact with various environmental xenobiotics, and so they should provide useful 
871 information on the initial response of cells to exposure. Another characteristic of most of the 
872 cell types is that they have a rapid turnover; therefore they would only reflect recent events 
873 that affected DNA repair. Future studies are needed, addressing the quality and quantity of 
874 exfoliated cells that need to be obtained in order to apply the in vitro repair assays. Cell 
875 recovery should be high enough to make extracts of sufficient volume and protein 
876 concentration to apply to substrate cells. Cell counts may be insufficient for buccal cells 
877 obtained by mouth rinsing or cheek scrapings (unpublished data). Cell counts are in theory 
878 sufficiently high for epithelial cells in urine [117]. Broncho-alveolar lavages [118] and induced 
879 sputum [119] also produce a sufficient number of cells, but these are predominantly 
880 leukocytes. It should also be noted that repair activity measurements in lavages from the 
881 airways are complicated by the fact that respirable toxicants can induce the influx of cells from 
882 the blood and the composition of cells in the broncho-alveolar lavage fluid is dependent on the 
883 type and stage of pulmonary inflammation. The applicability of epithelial cells for the repair 
884 assays needs to be established, as a large proportion of the exfoliated cells may be dead. For 
885 small (needle) biopsies an amount of approx. 5 mg of tissue should be enough to make protein 
886 extracts [38].
887
888 7. Discussion and conclusion
889 The comet assay and its modifications to measure DNA repair activity are frequently used in 
890 human biomonitoring studies. However, for the correct interpretation of the data of such 
891 biomonitoring studies, validation studies are needed that have to date not been performed in 
892 a systematic way. In this manuscript, we have compiled the information that is needed for the 
893 validation of the DNA repair comet assays, including intra- and inter-Individual variation, repair 
894 kinetics, the use of surrogate tissues, and comparison with other methods. 
28
895 The intra-individual variation over a relatively short period of time (weeks to several months) 
896 was reported to be small for both NER and BER, because measurements in the same 
897 individuals at two different moments correlated significantly and the slope of the regression 
898 line was close to 1.0. This indicates that the measurement of DNA repair activity reflects an 
899 individual’s intrinsic repair activity. 
900 How a low DNA repair activity should be interpreted is an open question; a person can have a 
901 low repair activity and may thus have a higher cancer risk, but it is also possible that low DNA 
902 repair activity simply reflects the absence of exposure, and thus DNA repair is not needed. 
903 Therefore, for proper interpretation of DNA repair activity data, a combined analysis with 
904 exposure data and/or other biomarkers (particularly DNA damage) is required. 
905 It is important to understand the kinetics of DNA repair after exposure. If DNA repair is 
906 measured shortly after a DNA damaging exposure, DNA repair may still be induced. On the 
907 other hand, when repair activity is assessed at a later time point relative to the exposure, DNA 
908 damage may already be removed and repair is no longer needed. Knowledge about the 
909 inducibility of DNA repair is therefore indispensable. 
910 The literature is equivocal about the regulation of BER, but NER is likely to be inducible. The 
911 different DNA repair pathways are likely to have different modes of regulation. BER often deals 
912 with DNA damage induced by endogenously produced DNA reactive compounds. For instance, 
913 reactive oxygen species are continuously present (and needed) in the body, but can also lead 
914 to oxidised DNA bases. Therefore, these oxidised DNA bases can be considered as physiological 
915 DNA lesions and the enzymes involved in BER are thus assumed to be in some way 
916 constitutive. In contrast, NER most often deals with damage caused by exogenous agents (i.e., 
917 chemicals and radiation), so the enzymes involved in this pathway are probably only 
918 synthesized when needed in episodes of increased exposure. 
919 This inducibility of NER may also be reflected in the inter-individual variation that is observed 
920 in the general population, because the inter-individual variation in NER is reportedly higher 
921 than the variation in BER. The inducibility of NER may be related to lifestyle factors in 
922 combination with the genetic background. Surprisingly, some healthy subjects seem to have 
923 undetectable levels of NER when using comet assay approaches, which could reflect a lack of 
924 exposure or a limitation of the comet assay approach. This observation therefore needs 
925 confirmation by using other assays. For interpreting NER data, we therefore suggest that these 
926 should always be combined with exposure data. 
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927 Although the literature suggests that BER activity is less inducible, some studies showed that 
928 dietary interventions may still increase BER activity. Induction of repair activity can, of course, 
929 occur post-translationally as well as at the level of transcriptional regulation. Therefore, more 
930 work is needed to understand the impact of lifestyle, including genetic background, exposure 
931 and dietary habits on both BER and NER activity. 
932 Human biomonitoring studies most of the time use leukocytes or PBMCs to assess DNA repair 
933 activity. Only a limited number of studies showed a correlation between DNA repair in PBMCs 
934 and the target tissue cells, so more work is needed to confirm that repair in blood cells actually 
935 reflects the intrinsic repair capacity of internal organs. However, the work that has been 
936 published to date looks promising. The total blood cell population (i.e., leukocytes) consists of 
937 different cell types including monocytes, lymphocytes and granulocytes. These cell types have 
938 differences in life span, concentrations in blood and most probably also different levels of DNA 
939 repair. If common diseases, such as a simple cold, affect blood composition, this could change 
940 the repair activity that is measured when using total WBC. In that case, differences in DNA 
941 repair activity between or within individuals could be related to the percentages of the 
942 different cell types in the blood sample. One should keep in mind that isolating blood cell 
943 subpopulations automatically requires more work and hands-on time when preparing the 
944 samples and this may not always be feasible in large scale biomonitoring studies. Therefore, a 
945 more thorough understanding of DNA repair in blood cell subpopulations may guide the 
946 decision to use total white blood cells, isolated PBMCs or PBMC subpopulations in human 
947 biomonitoring studies.
948 It is worth to mention that conflicting results observed in some of the studies summarised in 
949 this review can be due to the small sample size. However, these studies often show biologically 
950 relevant effects and can give important information for larger future studies. More studies 
951 with higher samples size are needed. 
952 However, in order to analyze large numbers of samples in a limited amount of time, as is often 
953 the case in human biomonitoring, there is a need to develop high throughput approaches; for 
954 instance the CometChip is an approach to be explored [120]. Even if the number of samples 
955 per run is increased, samples may still be analysed in batches. To avoid batch differences, the 
956 comet assay should be further optimized by, for instance, standardizing the preparation of 
957 substrate cells, including positive and negative controls, and using assay controls. Although the 
958 COST-Action hCOMET (CA15132) may address some of these issues, it will need concerted 
959 action by the comet assay community to carry out a full technical and field validation of the 
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960 repair comet assay, to reduce inter-assay and inter-laboratory variations, and to ensure the 
961 proper comparison and interpretation of results of biomonitoring studies. 
962
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1343 Figure 1: Scheme of the cellular repair assay. Nucleoids can either be incubated with lesion-
1344 specific enzymes (to assess various specific DNA lesions) or not (to assess SBs). The formation 
1345 and removal of DNA lesions is studied over time, requiring multiple cell incubations
1346
1347 Figure 2: Scheme of the in vitro repair assay. Substrate cells can be exposed to the 
1348 photosensitizer Ro 19-8022 plus light to induce 8-oxodG lesions or to UV to induce primer 
1349 dimers, allowing the assessment of BER and NER incision activity respectively. After lysis, gel-
39
1350 embedded nucleoids are incubated with protein extracts for cells in culture, blood or tissues. 
1351 Subsequent standard single-cell gel electrophoresis reveals the SSBs introduced by the DNA 
1352 repair enzymes. The addition of dNTPs to the extracts would allow to study DNA 
1353 synthesis/ligation capacity in parallel to DNA incision activity. 
1354 Figure 3: Correlation between repair activities in extracts from human lymphocytes taken at 
1355 different dates (approximately 2 months apart) and analysed using the BER (A) and NER (B) in 
1356 vitro repair assay. Taken from [32], with permission.
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1358 Table 1. Overview of human DNA repair mechanims. Taken from [3], with permission.
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1360 Table 2. Correlation coefficients, R, for repair rates of 33 individuals at different sampling times 
1361 (blood samples were taken approximately 4 weeks apart). * p<0.05. Adapted from [32], with 
1362 permission.
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1364 Table 3. Inter-individual variation in repair activity using different assays. Data from samples 
1365 taking at two occasions were available; mean values were used to estimate the range. Adapted 
1366 from [12], with permission.
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1368 Table 4. Studies on association between age and DNA repair activity in leukocytes, 
1369 lymphocytes or peripheral mononuclear blood cells.
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1371 Table 5. Studies on association between dietary factors and DNA repair activity in  leukocytes, 
1372 lymphocytes or peripheral mononuclear blood cells.
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1374 Table 6. Sources of exfoliated cells that can be collected in human biomonitoring studies
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 DNA in tail =  Incision activityDNA damage recognition and incision 
during incubation step at 37°C

 Repair pathway Damage repaired Sources of damage
Direct reversal
Alkylated base O6 -methyl-
guanine, pyrimidine dimers (by 
photolyase)
Alkylating agents, nitrosoureas, streptozotocin, UV(C) 
light
Base excision repair
Oxidised bases, alkylated bases, 
abasic/apurinic/apyrimidinic 
sites, single-strand breaks
Reactive oxygen species (ROS), alkylating agents, ionizing 
radiation, spontaneous hydrolysis
Nucleotide excision repair
Bulky helix-distorting lesions, 
intra-strand cross links, DNA-
protein cross links, inter-strand 
cross links
UV(C) light, cigarette smoke, dietary factors (aflatoxin, 
poly-aromatic hydrocarbons (benzo(a)pyrene))
Mismatch repair Mismatched base pairs, small insertion loops
Replication errors, minor base modifications (oxidation, 
alkylation)
Double-strand break repair (i.e., homologous 
recombination and non-homologous end-
joining)
Double-strand breaks Ionising radiation, replication errors
T=0 T ≈ 4 weeks T ≈ 8 weeks T ≈ 12 weeks T ≈ 16 weeks
BER
T ≈ 4 weeks 0.25
T ≈ 8 weeks 0.42* 0.11
T ≈ 12 weeks 0.40* 0.50* 0.30
T ≈ 16 weeks 0.60* 0.08 0.62* 0.38*
T ≈ 20 weeks 0.50* 0.35* 0.12 0.32 0.47*
NER
T ≈ 4 weeks 0.40*
T ≈ 8 weeks 0.32 0.60*
T ≈ 12 weeks 0.51* 0.64* 0.52*
T ≈ 16 weeks 0.44* 0.54* 0.48* 0.40*
T ≈ 20 weeks 0.45* 0.42* 0.18 0.31 0.59*
Lesion repaired Assay N Range (fold) Source of variation Reference
AP-sites Plasmid 10 2.5 Healthy individuals (age: 25-48 years). Authors did not correlate repair 
with other parameters.
[18]
8-OxoG Oligonucleotide 34 2 Healthy individual (age: 18-60). There was no difference in OGG1 activity 
due to gender and smoking behaviour. Authors did not report age effect. 
OGG1 polymorphism not associated with altered OGG1 activity.
[70]
8-OxoG Oligonucleotide 120 2.8 Healthy individuals. No significant differences between males and 
females, or between smokers and non-smokers. OGG1 activity was 
significantly lower in males older than 55 years compared to younger 
subjects. This effect was not observed in females.
[24]
8-OxoG In vitro comet 
assay
35 3 Healthy individuals from intervention study (no effect of the intervention 
on DNA repair capacity). No further data on individuals’ characteristics 
reported. Authors did not correlate repair with other parameters.
[32]
8-OxoG In vitro comet 
assay
40 41 Individuals from 18 to 30 years old. Association between endogenous SBs 
and BER was not observed. Authors did not correlate repair with other 
parameters..
[71]
UV-induced 
damage
Host cell 
reactivation 
assay (HCRA): 
catalase and 
luciferase assay
102 4.7 (luciferase 
assay)
7 (catalase 
assay)
Healthy subjects (age: 19-79). Authors did analyze correlation with age 
or other factors.
[72]
UV-induced 
damage
In vitro comet 
assay
33 7 Healthy individuals from intervention study (no effect of the intervention 
on DNA repair capacity). No further data on individuals’ characteristics 
reported. Authors did not correlate repair with other parameters.
[32]
UV-induced 
damage
Host cell 
reactivation
63 11 Individuals from an intervention study (age: 18-30, no effect of the 
intervention on DNA repair capacity). NER capacity was inversely 
associated with age, endogenous DNA SBs and BMI (adiposity).
[73]
Benzo(a)pyrene In vitro comet 
assay
8 10 Healthy individuals; no further data. Authors did not correlate repair with 
other parameters.
[31] 
BPDE- induced 
damage
Aphidicoline-
block cellular 
comet assay
122 40 Healthy people (age: 19-48, cropreserved lymphocytes). Authors did not 
correlate repair with other parameters.
[51]

1Country (age) number of 
females (F) and males 
(M)
Cell type Comet repair assay 
(substrate)
Effect on DNA repair biomarker Adjustment Reference
Slovakia (21-88 years, 
227 M, 161 F) recruited 
from factories with 
occupational exposure to 
asbestos, stone wool or 
glass fibres and controls 
matched for age, sex, 
alcohol consumption and 
smoking
Lymphocytes 
(frozen)
In vitro repair 
(Ro19-8022 + light, 
Hela cells, 10 min 
incubation)
Positive association between age 
and repair incision activity (r = 
0.1, P<0.05, correlation analysis 
not specified)
No control for 
confounding (with 
regard to age-
dependent effects 
on DNA repair 
incision activity)
[69]
UK (young (20-35 years), 
middle (63-70 years) or 
old (75-82 years), n = 97, 
MF). Sampled from areas 
near Bristol, London, 
Wisbech, Aberdeen and 
Dundee 
Lymphocytes 
(frozen)
In vitro repair 
(Ro19-8022 + light, 
Hela cells 10 min 
incubation)
Positive association between age 
and repair incision activity (r = 
0.25, P = 0.06, Pearson 
correlation). Statistically 
significant group difference when 
tested by ANOVA
No control for 
confounding
[82]
Czech Republic (41 ± 11 
years, 183 M, 61 F) 
recruited in local 
administration, medical 
centres and various 
branches of plastic 
industry
Lymphocytes 
(fresh for 
repair of DNA 
strand breaks, 
frozen for in 
vitro repair 
assay)
In vitro repair 
(Ro19-8022 + light, 
Hela cells, 10 min 
incubation)
Repair of gamma 
radiation induced 
DNA strand breaks 
(5 Gy)
No association between age and 
repair incision activity and 
gamma radiation-induced DNA 
strand breaks (results not shown, 
type of control for confounding 
not specified in detail)
Analysed by both 
simple and 
multivariate 
regression analysis
[83]
USA (30-64 years, 48F, 
48M) of White and 
African America race
PBMCs 
(frozen)
Repair of gamma 
radiation induced 
DNA strand breaks 
(6.3 Gy)
Positive association between age 
and repair activity in White 
females (r = 0.55, P < 0.01) and 
borderline statistical significance 
(r = -0.40, P = 0.06, linear 
regression) in African-American 
females. No effect in White or 
African-American males
Matched in sex and 
race strata
[84]
2Denmark (18-83 years, 
40 M, 38 F) from a 
national health survey in 
Copenhagen 
PBMCs 
(frozen)
In vitro repair 
(KBrO3, THP-1 cells 
45 min incubation)
Inverse association between age 
and repair incision activity in 
women, but not in men. Decline 
in repair activity per year was 
0.65% per year (95% CI: 0.16% – 
1.14%) in multivariate regression 
analysis
Sex, body mass index 
(or waist-hip ratio), 
blood pressure, 
cholesterol, 
triglycerides, Hb1Ac, 
C-reactive protein, 
smoking and alcohol
[30]
 
1Country (age) number of 
females (F) and males 
(M)
Cell type Comet repair assay 
(substrate)
Effect on DNA repair biomarker Effect on 
phytochemical
Reference
Sequential study of non-
smokers (20-50 years, n = 
6, M, Scotland) ingesting  
100 mg/day of CoQ10 for 
1 week and a subsequent 
washout period of 1 
week
Lymphocytes 
(fresh)
In vitro repair 
(Ro19-8022 + light, 
lymphocytes, 20 
min incubation)
Increased repair incision activity 
after supplementation compared 
to pre-supplementation. 
Decreased levels compared to 
supplementation period, 
although not statistically 
significant, after 1 week washout 
period
Increased CoQ10 
concentration in plasma
[92]
Cross-over study on 
healthy non-smoking 
subjects (26-54 years, n = 
14, MF, Scotland) 
ingesting 1, 2 or 3 
kiwifruits/day for 3 
weeks
Lymphocytes 
(fresh)
In vitro repair 
(Ro19-8022 + light, 
Hela cells, 10 min 
incubation)
Increased repair incision activity 
after consumption of kiwifruits 
(similar effect of 1-3 
kiwifruits/day)
Increased plasma 
concentration of 
vitamin C concentration
[93]
Placebo-controlled 
parallel trial on non-
smokers (18-50 years, n = 
20, UK) ingesting tablets 
with α-carotene (3.7 mg) 
and β-carotene (8.2 mg) 
for 3 weeks 
Lymphocytes 
(fresh)
Repair of H2O2 
induced DNA 
strand breaks (100 
µM)
DNA repair of DNA strand breaks 
over a 4 h incubation period (no 
repair in cells from the placebo 
group). Groups of subjects with 
intake of cooked carrots, 
mandarin oranges and vitamin C 
tablets were included in the 
study, but the results are not 
reported (risk of reporting bias)
Increased plasma 
concentration of β-
carotene
[94]
Placebo-controlled 
parallel trial on non-
smokers (20-60 years, n = 
61, MF, UK) ingesting 
folic acid (1.6 mg/day) for 
12 weeks
Lymphocytes 
(not specified)
In vitro repair 
(Ro19-8022 + light, 
CHO cells 20 min 
incubation)
Unaltered levels of repair incision 
activity in the whole study 
population. A restricted analysis 
of the quartile with lowest 
baseline red cell folate 
concentration showed a 
reduction of repair incision 
activity in the folate 
Increased 5-
methyltetrahydrofolate  
concentration in 
plasma, erythrocytes, 
and lymphocytes
[90]
2supplementation group (risk of 
bias due to subgroup analysis and 
unequal baseline folate 
concentration between 
supplementation and placebo 
group)
Cross-sectional study of 
(young (20-35 years), 
middle (63-70 years) or 
old (75-82 years), n = 97, 
MF) from areas near 
Bristol, London, Wisbech, 
Aberdeen and Dundee 
Lymphocytes 
(frozen)
In vitro repair 
(Ro19-8022 + light, 
Hela cells 10 min 
incubation)
Inverse correlation between 
plasma concentration of 
lutein/zeaxanthin (r = -0.31, P = 
0.06, Pearson correlation).
Marginally positive association 
with retinol (r = 0.25, P = 0.06). 
No correlation with vitamin C, β-
carotene, lycopene and α-
tocopherol. No control for 
confounding
Not applicable [82]
Placebo-controlled 
parallel trial on smokers 
(39 ± 12 years, n = 48, M, 
Denmark) ingesting 500 
mg vitamin C and 182 mg 
vitamin E per day for 4 
weeks
PBMCs 
(frozen)
In vitro repair 
(Ro19-8022 + light, 
A549 cells, 20 min 
incubation)
Increased repair incision activity 
in the group of subjects who 
ingested vitamin C and E as slow-
release tablets. No effect in the 
group that received tablets with 
fast-release tablets
Increased vitamin C in 
plasma after ingestion 
of both slow- and fast-
release tablets
[39]
Placebo-controlled 
parallel trial on non-
smokers (27 ± 6 years, n 
= 43, MF, Denmark) 
ingesting 600 g 
fruit/vegetables or 
tablets with the 
corresponding amount of 
vitamins and minerals for 
4 weeks
PBMCs 
(frozen)
In vitro repair 
(Ro19-8022 + light, 
A549 cells, 20 min 
incubation)
Unaltered levels of repair incision 
activity
Strong decrease in 
plasma vitamin C in the 
placebo group. 
Increased lycopene 
levels (fruit/vegetable 
group) and β-carotene 
(tablet group)
[39]
Sequential study of non-
smokers (18-45 years, n = 
Lymphocytes 
(frozen)
In vitro repair 
(benzo[a]pyrene-
Unaltered levels of repair incision 
activity
Not reported [60]
336, MF, Netherlands), 
selected according to 
ERCC1 genotype, 
ingesting  blueberry and 
apple juice for 4 weeks 
after a 5-day washout 
period
diolepoxide, cells 
or incubation not 
reported)
Placebo-controlled 
parallel trial on non-
smokers (18-30 years, n = 
48, MF, UK) ingesting a 
supplement (100 µg 
Selenium, 450 µg vitamin 
A, 450 µg retinol, 90 mg 
vitamin C and 30 mg/ 
vitamin E) for 6 weeks
Lymphocytes 
(frozen)
In vitro repair 
(Ro19-8022 + light, 
Hela cells, 20 min 
incubation)
Unaltered levels of repair incision 
activity
Not reported [71]
Cross-over study on 
smokers (22 ± 3 years, 
sex not specified, Italy) 
ingesting steamed 
broccoli (250 g/day) for 
10 days
PBMCs 
(frozen)
In vitro repair 
(Ro19-8022 + light, 
A549 cells, 20 min 
incubation)
Unaltered levels of repair incision 
activity
Increased plasma 
concentration of folate 
and lutein. Unaltered 
levels of β-carotene
[91]
Placebo-controlled 
parallel trial on smokers 
(45-75 years, n = 69, M, 
Norway) ingesting 
kiwifruit or a 
phytochemical-rich diet 
for 8 weeks
Lymphocytes 
(frozen)
In vitro repair 
(Ro19-8022 + light, 
substrate cell not 
reported, 20 min 
incubation; UV-C, 
substrate cell not 
reported, 30 min)
Increased base excision (Ro19-
8022 + light) and decreased 
nucleotide excision (UV-C) repair 
in both kiwifruit and 
phytochemical-rich diet group
Increased vitamin C 
(both groups). Increased 
β-carotene and 
tocopherol in the 
phytochemical-rich 
group
[62]
Target tissue Surrogate tissue How to obtain cells
Bladder Exfoliated epithelial cells  Isolate from urine 
Upper respiratory tract Buccal cells
Nasal epithelial cells
Mouth cells
 Mouth rinse or scraping
 Nasal lavage
 Isolate from saliva
Lower respiratory tract Lung derived cells  Isolate cells from induced 
or spontaneously produced 
sputum 
 Broncho-alveolar lavage
Colon Exfoliated epithelial cells  Isolate from stool
Mammary Exfoliated epithelial cells Isolate from 
 Nipple aspirate
 Ductal lavage
 Breast milk
Prostate / testis Epithelial cells
spermatozoa 
 Isolate from ejaculate
Other tissues  Biopsy (invasive)
